In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

Publisher:
Mary Ann Liebert Inc Publ
Publication Type:
Journal Article
Citation:
Human Gene Therapy, 1998, 9 (11), pp. 1617 - 1626
Issue Date:
1998-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010000589OK.pdf735.22 kB
Adobe PDF
Advanced prostate cancer is invariably lethal once it becomes androgen independent (AI). With the aim of developing a new treatment we have used the human androgen-independent prostate cancer cell line, PC-3, to evaluate the effectiveness of two enzyme-d
Please use this identifier to cite or link to this item: